Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 1 June, 2019
PD-L1 (for recurrent or metastatic triple-negative breast CA)
By
vgreene
, 1 June, 2019
HER2 biomarker
By
vgreene
, 1 June, 2019
Progesterone receptor biomarker
By
vgreene
, 1 June, 2019
Tissue Biomarkers for Common Cancers | epocrates Quick Look
By
vgreene
, 1 June, 2019
HR- HER2+ patient
By
vgreene
, 1 June, 2019
HR+/HER2+ patient
By
vgreene
, 1 June, 2019
HR+/HER2-patient
By
vgreene
, 1 June, 2019
PD-L1
By
vgreene
, 1 June, 2019
Non triple-negative breast CA patient
By
vgreene
, 1 June, 2019
Estrogen receptor biomarker
Pagination
First page
Previous page
…
Page
2379
Page
2380
Page
2381
Page
2382
Current page
2383
Page
2384
Page
2385
Page
2386
Page
2387
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube